.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2015 for an enormou...
.On the heels of a stage 3 win that failed to wow investors, Ironwood Pharmaceuticals is back along ...
.Do not stop Monte Rosa Therapies right now. The Boston-based biotech is enjoying after authorizing ...
.Welcome to recently's Chutes & Ladders, our roundup of notable management hirings, shootings and...
.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the positio...
.AbbVie has actually returned to the source of its own antipsychotic giant Vraylar seeking one more ...
.GenSight Biologics is actually weeks off of losing money. Once more. The biotech simply has adequat...
.Monopar Therapeutics is actually bouncing back a drug from the dump of AstraZeneca's unusual diseas...
.Along with brand new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...
.After creating a genetics treatment collaboration along with Dyno Therapies in 2020, Roche is actua...